Annual Current Liabilities
$804.40 M
+$461.20 M+134.38%
31 December 2023
Summary:
United Therapeutics annual total current liabilities is currently $804.40 million, with the most recent change of +$461.20 million (+134.38%) on 31 December 2023. During the last 3 years, it has risen by +$499.00 million (+163.39%). UTHR annual current liabilities is now at all-time high.UTHR Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$873.40 M
+$41.10 M+4.94%
30 September 2024
Summary:
United Therapeutics quarterly total current liabilities is currently $873.40 million, with the most recent change of +$41.10 million (+4.94%) on 30 September 2024. Over the past year, it has increased by +$69.00 million (+8.58%). UTHR quarterly current liabilities is now at all-time high.UTHR Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
UTHR Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +8.6% |
| 3 y3 years | +163.4% | +186.0% |
| 5 y5 years | +73.7% | +88.6% |
UTHR Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +163.4% | at high | +198.5% |
| 5 y | 5 years | at high | +163.4% | at high | +321.3% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
United Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $873.40 M(+4.9%) |
| June 2024 | - | $832.30 M(-3.3%) |
| Mar 2024 | - | $860.60 M(+7.0%) |
| Dec 2023 | $804.40 M(+134.4%) | $804.40 M(+8.1%) |
| Sept 2023 | - | $744.10 M(+100.9%) |
| June 2023 | - | $370.30 M(+14.1%) |
| Mar 2023 | - | $324.60 M(-5.4%) |
| Dec 2022 | $343.20 M(+12.4%) | $343.20 M(+8.6%) |
| Sept 2022 | - | $315.90 M(-4.7%) |
| June 2022 | - | $331.50 M(+13.3%) |
| Mar 2022 | - | $292.60 M(-4.2%) |
| Dec 2021 | $305.40 M(-5.5%) | $305.40 M(-4.6%) |
| Sept 2021 | - | $320.00 M(+2.8%) |
| June 2021 | - | $311.40 M(+3.0%) |
| Mar 2021 | - | $302.40 M(-6.5%) |
| Dec 2020 | $323.30 M(-30.2%) | $323.30 M(+24.9%) |
| Sept 2020 | - | $258.90 M(+1.5%) |
| June 2020 | - | $255.00 M(+23.0%) |
| Mar 2020 | - | $207.30 M(-55.2%) |
| Dec 2019 | $463.00 M(+67.4%) | $463.00 M(-1.5%) |
| Sept 2019 | - | $469.90 M(+1.4%) |
| June 2019 | - | $463.50 M(+71.7%) |
| Mar 2019 | - | $270.00 M(-2.4%) |
| Dec 2018 | $276.60 M(-37.8%) | $276.60 M(-25.7%) |
| Sept 2018 | - | $372.40 M(+6.4%) |
| June 2018 | - | $350.00 M(+9.9%) |
| Mar 2018 | - | $318.40 M(-28.4%) |
| Dec 2017 | $444.70 M(+33.7%) | $444.70 M(-43.7%) |
| Sept 2017 | - | $789.40 M(-5.9%) |
| June 2017 | - | $838.80 M(+96.1%) |
| Mar 2017 | - | $427.70 M(+28.6%) |
| Dec 2016 | $332.50 M(-24.6%) | $332.50 M(+5.7%) |
| Sept 2016 | - | $314.60 M(+7.6%) |
| June 2016 | - | $292.40 M(-18.1%) |
| Mar 2016 | - | $357.10 M(-19.0%) |
| Dec 2015 | $440.70 M(-12.6%) | $440.70 M(-20.9%) |
| Sept 2015 | - | $557.34 M(+2.8%) |
| June 2015 | - | $542.41 M(-16.1%) |
| Mar 2015 | - | $646.75 M(+28.2%) |
| Dec 2014 | $504.31 M(-26.7%) | $504.31 M(-33.7%) |
| Sept 2014 | - | $760.65 M(+15.4%) |
| June 2014 | - | $659.07 M(+0.1%) |
| Mar 2014 | - | $658.53 M(-4.2%) |
| Dec 2013 | $687.67 M(+289.1%) | $687.67 M(+46.7%) |
| Sept 2013 | - | $468.91 M(+13.8%) |
| June 2013 | - | $412.23 M(+133.4%) |
| Mar 2013 | - | $176.60 M(-0.1%) |
| Dec 2012 | $176.75 M(-16.9%) | $176.75 M(-22.3%) |
| Sept 2012 | - | $227.62 M(+21.3%) |
| June 2012 | - | $187.66 M(+6.9%) |
| Mar 2012 | - | $175.54 M(-17.4%) |
| Dec 2011 | $212.58 M | $212.58 M(-50.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2011 | - | $424.95 M(-6.3%) |
| June 2011 | - | $453.54 M(+2.6%) |
| Mar 2011 | - | $441.95 M(+3.1%) |
| Dec 2010 | $428.69 M(+29.8%) | $428.69 M(+7.9%) |
| Sept 2010 | - | $397.46 M(+8.7%) |
| June 2010 | - | $365.72 M(+11.1%) |
| Mar 2010 | - | $329.04 M(-0.3%) |
| Dec 2009 | $330.19 M(+472.3%) | $330.19 M(+9.7%) |
| Sept 2009 | - | $301.03 M(+295.0%) |
| June 2009 | - | $76.22 M(+27.5%) |
| Mar 2009 | - | $59.76 M(+3.6%) |
| Dec 2008 | $57.69 M(-78.8%) | $57.69 M(-80.3%) |
| Sept 2008 | - | $293.13 M(-0.0%) |
| June 2008 | - | $293.22 M(+385.0%) |
| Mar 2008 | - | $60.45 M(-77.8%) |
| Dec 2007 | $272.76 M(+1316.9%) | $272.76 M(+731.8%) |
| Sept 2007 | - | $32.79 M(+40.7%) |
| June 2007 | - | $23.31 M(+21.2%) |
| Mar 2007 | - | $19.23 M(-0.1%) |
| Dec 2006 | $19.25 M(+32.5%) | $19.25 M(-3.8%) |
| Sept 2006 | - | $20.00 M(-16.1%) |
| June 2006 | - | $23.85 M(+34.7%) |
| Mar 2006 | - | $17.71 M(+21.9%) |
| Dec 2005 | $14.52 M(+4.8%) | $14.52 M(-15.2%) |
| Sept 2005 | - | $17.12 M(+8.7%) |
| June 2005 | - | $15.76 M(+32.1%) |
| Mar 2005 | - | $11.93 M(-14.0%) |
| Dec 2004 | $13.86 M(+30.6%) | $13.86 M(-2.3%) |
| Sept 2004 | - | $14.19 M(+25.5%) |
| June 2004 | - | $11.30 M(+15.1%) |
| Mar 2004 | - | $9.82 M(-7.5%) |
| Dec 2003 | $10.62 M(+14.1%) | $10.62 M(-39.2%) |
| Sept 2003 | - | $17.45 M(+40.0%) |
| June 2003 | - | $12.47 M(+12.9%) |
| Mar 2003 | - | $11.04 M(+18.7%) |
| Dec 2002 | $9.31 M(-13.8%) | $9.31 M(-5.0%) |
| Sept 2002 | - | $9.80 M(-11.4%) |
| June 2002 | - | $11.05 M(+39.4%) |
| Mar 2002 | - | $7.93 M(-26.6%) |
| Dec 2001 | $10.80 M(-6.0%) | $10.80 M(+12.7%) |
| Sept 2001 | - | $9.58 M(-19.6%) |
| June 2001 | - | $11.92 M(-1.8%) |
| Mar 2001 | - | $12.13 M(+5.6%) |
| Dec 2000 | $11.49 M(+149.8%) | $11.49 M(+45.6%) |
| Sept 2000 | - | $7.89 M(+16.4%) |
| June 2000 | - | $6.78 M(+34.8%) |
| Mar 2000 | - | $5.03 M(+9.4%) |
| Dec 1999 | $4.60 M(+155.6%) | $4.60 M(+100.0%) |
| Sept 1999 | - | $2.30 M(+155.6%) |
| June 1999 | - | $900.00 K(-55.0%) |
| Mar 1999 | - | $2.00 M |
| Dec 1998 | $1.80 M | - |
FAQ
- What is United Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for United Therapeutics?
- What is United Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for United Therapeutics?
- What is United Therapeutics quarterly current liabilities year-on-year change?
What is United Therapeutics annual total current liabilities?
The current annual current liabilities of UTHR is $804.40 M
What is the all time high annual current liabilities for United Therapeutics?
United Therapeutics all-time high annual total current liabilities is $804.40 M
What is United Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of UTHR is $873.40 M
What is the all time high quarterly current liabilities for United Therapeutics?
United Therapeutics all-time high quarterly total current liabilities is $873.40 M
What is United Therapeutics quarterly current liabilities year-on-year change?
Over the past year, UTHR quarterly total current liabilities has changed by +$69.00 M (+8.58%)